Get the Stockscreener App
1.71
2.84%
-0.05
Microbot Medical Inc stock is traded at $1.71, with a volume of 369.23K.
It is down -2.84% in the last 24 hours and down -4.47% over the past month.
Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.
See More
Previous Close:
$1.76
Open:
$1.76
24h Volume:
369.23K
Relative Volume:
0.30
Market Cap:
$114.85M
Revenue:
-
Net Income/Loss:
$-14.21M
P/E Ratio:
-6.1822
EPS:
-0.2766
Net Cash Flow:
$-15.38M
1W Performance:
-2.29%
1M Performance:
-4.47%
6M Performance:
-13.64%
1Y Performance:
-37.59%
1-Day Range:
$1.70
$1.77
1-Week Range:
$1.70
$1.83
52-Week Range:
$1.6001
$4.67
Microbot Medical Inc Stock (MBOT) Company Profile
Name
Microbot Medical Inc
Sector
Industry
Phone
908-938-5561
Address
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Compare MBOT vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
1.71 | 114.85M | 0 | -14.21M | -15.38M | -0.2766 |
ISRG
Intuitive Surgical Inc
|
337.50 | 120.92B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
156.36 | 43.08B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.91 | 33.12B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
38.75 | 32.77B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
195.27 | 28.33B | 5.54B | 1.52B | 1.74B | 10.37 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-26 | Initiated | B. Riley Securities | Buy |
| Dec-03-25 | Initiated | Roth Capital | Buy |
| Jan-13-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-24-19 | Reiterated | H.C. Wainwright | Buy |
| Jan-31-18 | Initiated | Ladenburg Thalmann | Buy |
Microbot Medical Inc Stock (MBOT) Latest News
New Strong Buy Stocks for July 23rd - The Globe and Mail
Microbot Medical Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026 - 富途牛牛
Microbot Medical Inc. (MBOT) Stock Price, News, Quote & History - Yahoo! Finance Canada
Microbot Medical Inc (STU:CY9D) Stock Price & 30 Year Financial Data - GuruFocus
Microbot Medical to Present on Endovascular Robotics at Society of Robotic Surgery Annual Meeting - Quiver Quantitative
Microbot Medical CEO to Present on Endovascular Robotics at SRS Annual Meeting - TradingView
Microbot Medical® Among Featured Companies Showcasing Novel - GlobeNewswire
Microbot Medical Among Featured Companies Showcasing Novel Robotic Technologies and Digital Surgery Applications at the Society of Robotic Surgery Annual Meeting - Moomoo
MBOT Stock Falls As Investors Ponder Impact Of Geopolitical Tensions On Israel-Founded Company - Stocktwits
MBOT News Today | Why did Microbot Medical stock go down today? - MarketBeat
Microbot Medical sees 100%+ Q2 revenue growth as LIBERTY adoption grows - MSN
H.C. Wainwright reiterates Microbot Medical stock rating on strong revenue growth - Investing.com Nigeria
H.C. Wainwright Maintains Microbot Medical(MBOT.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Microbot Medical reports 100% revenue growth in Q2 2026 - Medical Buyer
Is Sanmina (SANM) Quietly Reframing Its Growth Narrative Through Microbot’s LIBERTY Deal? - simplywall.st
ETFs Investing in Microbot Medical Inc Stocks - TradingView
Microbot Medical (MBOT) Reports Over 100% Revenue Growth in Q2 2 - GuruFocus
Microbot Medical reports 100% revenue growth in Q2 - scanx.trade
Microbot Medical reports Q2 revenue growth, expands sales territories By Investing.com - Investing.com Nigeria
Microbot Medical reports Q2 revenue growth, expands sales territories - Investing.com
Microbot Medical® Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026 - The Manila Times
Microbot Medical (NASDAQ: MBOT) more than doubles Q2 revenue as LIBERTY adoption rises - Stock Titan
Press Release: Microbot Medical(R) Reports Over 100% Revenue and Customer Growth as Procedure Volume Also Rises in the Second Quarter of 2026 - Moomoo
Microbot Medical (MBOT) Inches Higher, Holds Above Support as Volume Picks UpMedian Line - dars.gov.et
After plunging 22.6% in 4 weeks, here's why the trend might reverse for Microbot Medical (MBOT) - MSN
MBOTMicrobot Medical Inc Latest SEC Filings - Finviz
Sanmina to manufacture Microbot Medical’s LIBERTY Endovascular Robotic System - Today's Medical Developments
Microbot Medical Inc. (MBOT) reports Q1 loss, misses revenue estimates - MSN
symbol__ Stock Quote Price and Forecast - CNN
Why Is Sanmina (SANM) Stock Soaring Today - TradingView
Microbot Medical (MBOT) Partners with Sanmina for Manufacturing Expansion - GuruFocus
Microbot Medical Inc. Enters into Manufacturing Agreement with Sanmina Corporation for the Liberty Endovascular Robotic System - marketscreener.com
Microbot Medical partners with Sanmina for device manufacturing By Investing.com - Investing.com South Africa
Microbot Medical partners with Sanmina for device manufacturing - Investing.com
Microbot Medical Expands LIBERTY® System Manufacturing with Sanmina Partnership to Meet Rising Global Demand - Minichart
Microbot Medical® Increases Manufacturing Capacity as Demand for the LIBERTY® System Rises; Enters into Strategic Agreement with Sanmina, a Global Manufacturing Leader - marketscreener.com
Microbot Medical (NASDAQ: MBOT) taps Sanmina to expand LIBERTY production - Stock Titan
Microbot Medical Increases Manufacturing Capacity as Demand for the LIBERTY System Rises; Enters Into Strategic Agreement With Sanmina, a Global Manufacturing Leader - 富途牛牛
Microbot Medical partners with Sanmina to boost LIBERTY robotic system production amid rising demand. - Pluang
Microbot Medical Inc Actuals & Estimates (NASDAQ:MBOT) - TradingView
Microbot Medical | 8-K: Current report - Moomoo
Price to earnings forward of Microbot Medical Inc. – NASDAQ:MBOT - TradingView
Microbot Medical wins surgical robotics industry award for LIBERTY Endovascular Robotic System - Indian Pharma Post
MBOT Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Microbot Medical Inc – GETTEX:CY9D - TradingView
Microbot Medical’s LIBERTY® Wins Innovative Start-Up Award as First FDA-Cleared Single-Use Endovascular Robotic System – Minichart - Minichart
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System - The Manila Times
Microbot Medical Inc Stock (MBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.37%
0.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):